Known targets — ChEMBL curated mechanism
MMP1MMP13MMP7MMP8polrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Alcohol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.76 |
| ▸ | HTT | P42858 | 2/20 | 0.76 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.76 |
| ▸ | THRB | P10828 | 2/20 | 0.76 |
| ▸ | MAPT | P10636 | 1/20 | 0.76 |
| ▸ | TSHR | P16473 | 3/20 | 0.62 |
| ▸ | USP2 | O75604 | 1/20 | 0.58 |
| ▸ | CES2 | O00748 | 2/20 | 0.56 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.50 |
| ▸ | CES1 | P23141 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Alcohol SCHEMBL9213130 | 1.00 | MEN1 (0.76) | MEN1HTTKMT2ATHRBMAPT | |
| Alcohol SCHEMBL11759261 | 1.00 | MEN1 (0.76) | MEN1HTTKMT2ATHRBMAPT | |
| Alcohol SCHEMBL2637519 | 1.00 | MEN1 (0.76) | MEN1HTTKMT2ATHRBMAPT | |
| Alcohol SCHEMBL29018295 | 1.00 | MEN1 (0.76) | MEN1HTTKMT2ATHRBMAPT | |
| Alcohol SCHEMBL2695497 | 1.00 | MEN1 (0.76) | MEN1HTTKMT2ATHRBMAPT | |
| Alcohol SCHEMBL45307 | 0.97 | HTT (0.71) | MEN1HTTKMT2ATHRBMAPT | |
| Ethylene Glycol SCHEMBL11194102 | 0.95 | MEN1 (0.77) | MEN1HTTKMT2ATHRBMAPT | |
| Octane SCHEMBL8570538 | 0.94 | TSHR (0.70) | MEN1HTTKMT2ATHRBMAPT | |
| Ethylene Glycol SCHEMBL23391389 | 0.92 | MEN1 (0.81) | MEN1HTTKMT2ATHRBMAPT | |
| Ethylene Glycol SCHEMBL5616544 | 0.92 | MEN1 (0.81) | MEN1HTTKMT2ATHRBMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11555144-B2 | Colloidal disperse system suitable for phase inversion to stimulate hydrocarbon production wells | MOL MAGYAR OLAJ- ÉS GÁZIPARI NYILVÁNOSAN MÜKÖDÖ RÉSZVÉNYTÁRSASÁG (HU) | 2023-01-17 | — | — | US | claimed |
| EP-3898879-A1 | COLLIODAL DISPERSE SYSTEM SUITABLE FOR PHASE INVERSION TO STIMULATE HYDROCARBON PRODUCTION WELLS | MOL Magyar Olaj- és Gázipari Nyilvánosan Müködö Részvénytársaság (HU) | 2021-10-27 | — | — | EP | claimed |
| WO-2020128545-A1 | COLLIODAL DISPERSE SYSTEM SUITABLE FOR PHASE INVERSION TO STIMULATE HYDROCARBON PRODUCTION WELLS | MOL MAGYAR OLAJ- ÉS GÁZIPARI NYILVÁNOSAN MŰKÖDŐ RÉSZVÉNYTÁRSASÁG (HU) | 2020-06-25 | — | — | WO | claimed |
| CN-106118796-B | A method of preparing coal-based alcohol ether fuel adjunct using chemical byproduct | 安徽正洁高新材料股份有限公司 | 2018-09-07 | — | — | CN | claimed |
| CN-106118796-A | A kind of method utilizing chemical byproduct to prepare coal-based alcohol ether fuel adjunct | 安徽正洁高新材料股份有限公司 | 2016-11-16 | — | — | CN | claimed |
| WO-2023082780-A1 | MOLECULAR MARKER NICOTINE ASSOCIATED SNP 1 FOR IDENTIFYING CONTENT OF NICOTINE IN TOBACCO AND KIT AND APPLICATION THEREOF | 云南省烟草农业科学研究院 | 2023-05-19 | — | — | WO | disclosed |
| US-11555144-B2 | Colloidal disperse system suitable for phase inversion to stimulate hydrocarbon production wells | MOL MAGYAR OLAJ- ÉS GÁZIPARI NYILVÁNOSAN MÜKÖDÖ RÉSZVÉNYTÁRSASÁG (HU) | 2023-01-17 | — | — | US | disclosed |
| EP-3898879-A1 | COLLIODAL DISPERSE SYSTEM SUITABLE FOR PHASE INVERSION TO STIMULATE HYDROCARBON PRODUCTION WELLS | MOL Magyar Olaj- és Gázipari Nyilvánosan Müködö Részvénytársaság (HU) | 2021-10-27 | — | — | EP | disclosed |
| US-20200239813-A1 | METAL CLEANSER COMPOSITION | NICCA CHEMICAL CO., LTD. (JP) | 2020-07-30 | — | — | US | disclosed |
| WO-2020128545-A1 | COLLIODAL DISPERSE SYSTEM SUITABLE FOR PHASE INVERSION TO STIMULATE HYDROCARBON PRODUCTION WELLS | MOL MAGYAR OLAJ- ÉS GÁZIPARI NYILVÁNOSAN MŰKÖDŐ RÉSZVÉNYTÁRSASÁG (HU) | 2020-06-25 | — | — | WO | disclosed |
| US-10280385-B2 | Detergent composition for hard surfaces | NICCA CHEMICAL CO., LTD. (JP) | 2019-05-07 | — | — | US | disclosed |
| CN-109414460-A | Retinal vascular disease is treated using progenitor cells | 詹森生物科技公司 | 2019-03-01 | — | — | CN | disclosed |
| US-5006342-A | Resilient transdermal drug delivery device | CYGNUS CORPORATION (US) | 1991-04-09 | — | — | US | disclosed |
| US-4992381-A | Method of detecting electrolytes in an aqueous test sample using chromogenic hemispherands and test device therefor | TECHNICON INSTRUMENTS CORPORATION (US) | 1991-02-12 | — | — | US | disclosed |
| US-4911916-A | Diffusion matrix for transdermal drug administration and transdermal drug delivery devices including same | CYGNUS RESEARCH CORPORATION (US) | 1990-03-27 | — | — | US | disclosed |
| US-4906463-A | Transdermal drug-delivery composition | CYGNUS RESEARCH CORPORATION (US) | 1990-03-06 | — | — | US | disclosed |
| EP-0287330-A2 | Chromogenic hemispherands useful for detecting electrolytes | Bayer Corporation (US) | 1988-10-19 | — | — | EP | disclosed |
| EP-0287329-A2 | Chromogenic cryptahemispherands useful in detecting electrolytes | Bayer Corporation (US) | 1988-10-19 | — | — | EP | disclosed |
| EP-0272918-A2 | Diffusion matrix for transdermal drug administration and transdermal drug delivery devices including same | CYGNUS THERAPEUTIC SYSTEMS (US) | 1988-06-29 | — | — | EP | disclosed |
| EP-0272987-A2 | Resilient transdermal drug-delivery device and compositions and devices employing fatty acid esters/ethers or alkanediols as percutaneous absorption enhancers | CYGNUS THERAPEUTIC SYSTEMS (US) | 1988-06-29 | — | — | EP | disclosed |